Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace

Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace

Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace

Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility. Source:…

Sluggish growth is the main driver for the decision.. Source: BioSpace

Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy. Source: BioSpace

Vical announced its restructuring late Tuesday. Source: BioSpace

The company is now waiting for the FDA to determine a path forward in resuming clinical studies. Source: BioSpace

The bill would allow access to experimental treatments for patients with terminal conditions. Source: BioSpace

The companies were evaluated extensively on Career Pages, Job Boards, Employee Reviews & Candidate Engagement, Accolades, Recruitment Marketing, and Social Responsibility. Source: BioSpace